Something occurred to me as I am currently shopping for Health insurance. If Oxycontin has no generic on the market. Then there is clearly a need for generics, desire to lower health care costs etc...
As opioid generics are eliminated or look to be substituted for ADT versions, it makes perfect sense that the FDA would push through these generic versions very quickly..Between the urgency over abuse and urgency over costs and needing ADT and generic choices, these drugs likely get pushed in an expedited manner.
Well done research support to the reality of expedited review. What was it the NY Times called it? "Lightening quick!" Elite may or may not be so fortunate, but clearly it lies within the realm of possibility. Particular in light of the fact that, in response to the socio-political dynamics related to opioid abuse, the FDA has made it clear that it wants ART/ADT as a precursor to future approvals.